Opportunity
Simpler Grants.gov #PAR-25-063
NIH Grant for Assay Development and Screening in Psychiatric Disorder Research
Buyer
National Institutes of Health
Posted
November 06, 2024
Respond By
May 07, 2026
Identifier
PAR-25-063
NAICS
541714, 541715
This opportunity from the National Institutes of Health (NIH) supports research on novel small molecules for studying and treating psychiatric disorders. - Government Buyer: - National Institutes of Health (NIH) - Products/Services Requested: - Research services for assay development and screening related to brain disorders - Focus on discovery and development of novel small molecules - Generation of new biological insights into psychiatric disease processes - Eligibility and Requirements: - Open to government, nonprofit, business, and educational institutions - No clinical trials permitted under this grant - No cost sharing or matching required - Discretionary grant funding instrument - OEMs and Vendors: - No specific OEMs or vendors are named in the notice - Notable Requirements: - Emphasis on early-stage research and target discovery for mental health applications - Intended to advance understanding of disease biology, not to validate existing drug targets
Description
This Notice of Funding Opportunity (NOFO) aims to stimulate research focused on the discovery and development of novel small molecules for studying disease treatment relevant to psychiatric disorders. It also seeks to generate new insights into the biology of relevant diseases and processes that have not yet been validated as important drug targets. The funding is provided through grants and is open to a wide range of applicants including government entities, nonprofits, businesses, and educational institutions. The opportunity supports research that could lead to advancements in mental health treatment.